Vandetanib (ZD6474), a dual inhibitor of vascular endothelial growth factor receptor (VEGFR) and epidermal growth factor receptor (EGFR) tyrosine kinases: current status and future directions.
(Q37435425)
scientific article published on 06 April 2009
scientific article published on 06 April 2009
Language:
other details
description | scientific article published on 06 April 2009 |
External Links
(P356) |
10.1634/THEONCOLOGIST.2008-0261
|
(P698) |
19349511
|
(P5875) |
24260559
|
(P8608) |
release_bnu3nnj3mfe73pnb7v776npjmu
|